For years, hair restoration research has promised a lot and delivered just enough to keep hope alive. Now, scientists in Japan say they’ve crossed a line that matters: they’ve grown fully functional hair follicles in a lab for the first time. If that result holds up and eventually translates to humans, it could reshape how we think about baldness, scarring hair loss, and regenerative medicine more broadly.
What the RIKEN team actually achieved
The study, published in February 2026 in Biochemical and Biophysical Research Communications, comes from the RIKEN Centre for Biosystems Dynamics Research in Hyogo, Japan. The lead researchers were Koh-Ei Toyoshima and Takashi Tsuji, working with collaborators from OrganTech Inc. and TechnoPro Inc. in Tokyo, Iwate Medical University, Kitasato University, and Tokyo Dental College.
The headline result is not just that the team grew hair follicle-like structures. It’s that the follicles were fully functional. In other words, they behaved like real follicles rather than incomplete lab models that look promising under a microscope but fail to act like living skin biology.
The missing ingredient: a third cell type
Previous efforts usually relied on two major cell types: epithelial cells and mesenchymal cells. That approach could build parts of a follicle, but the follicles never fully functioned. They often lacked the organization and stability needed for natural cycling, which is the whole point of hair biology.
The RIKEN team found what appears to be the missing piece: accessory mesenchymal cells. These cells seem to act like structural scaffolding, stabilizing the bulge zone, the region where actual hair growth is coordinated. Once the researchers added this third cell type at the earliest stages, the lab-grown follicles started behaving much more like natural ones.
That timing matters. In development, order is everything. Add the right cells too late, and the tissue may form incorrectly or fail to mature. Add them early enough, and the follicle can assemble in a way that supports real biological function.
Why this is a bigger deal than a cool lab trick
One of the biggest reasons hair follicle engineering has been so difficult is that follicles are not static structures. They cycle through growth, rest, shedding, and regrowth. A follicle that can’t cycle is not much help if the goal is lasting hair restoration.
According to the RIKEN study, the follicles not only attached to surrounding tissue after surgery, they also progressed through normal growth cycles without needing a transplant first. Even more striking, they connected to the arrector pili muscles — the tiny muscles responsible for goosebumps. That connection suggests the follicles were integrating into tissue in a much more natural way than previous lab-grown attempts.
The team also reported that the follicles kept cycling for over 68 days after surgery. Hairs fell out and grew back naturally, which is exactly the kind of behavior researchers have been trying to achieve for years.
How this compares with earlier hair research
This breakthrough didn’t appear out of nowhere. It builds on a series of important steps in the field:
- 2022: Researchers at Yokohama National University grew hair follicles from rodent embryonic cells, with results published in Science Advances.
- 2023: Scientists at Rensselaer Polytechnic Institute 3D-printed hair follicles in lab-grown skin, also in Science Advances, but they could not achieve natural cycling.
- March 2026: L’Oréal Research and Queen Mary University London used 3D live imaging to observe individual cells inside living human hair follicles in Nature Communications.
What makes the RIKEN study stand out is that it is the first to demonstrate the full package: growth, rest, shedding, and regrowth in lab-grown follicles. That cycling problem has been one of the main barriers to turning hair follicle engineering into an actual therapy.
What it could mean for baldness treatment
Hair loss is a huge market because it’s a huge problem. The global hair loss treatment market is projected to reach $12.3 billion by 2026. That demand exists for a reason: around 40% of men experience hair loss by age 35, rising to 65% by age 60. More than 95% of male hair loss is androgenetic alopecia, better known as pattern baldness. Among women, more than 40% worldwide experience hair loss by age 40, and roughly 60% of the global population has some form of hair thinning.
Current treatments help, but they have limits. Minoxidil, sold as Rogaine, can slow shedding or stimulate some regrowth. Finasteride, sold as Propecia, can reduce the hormonal drivers of male pattern baldness. Hair transplants can work well too, but they simply move existing follicles from one place to another. They do not create new ones.
That is why this research matters so much. If scientists can reliably grow new follicles, the future of hair restoration could shift from redistribution to regeneration. In theory, that means unlimited new follicles rather than a finite supply of donor hair.
Beyond cosmetic hair loss
The implications go beyond appearance. Hair follicles are important skin structures, and the ability to grow them could help people with burn injuries, scarring alopecia, and other conditions where follicles are destroyed or permanently damaged. For those patients, this is not about vanity; it’s about restoring tissue that no longer functions normally.
There’s also a personalized medicine angle. If researchers can eventually grow follicles from a patient’s own cells, they may be able to reduce the risk of immune rejection and tailor treatment to the individual. That would be a major shift from today’s one-size-fits-most options.
Why scientists are excited, and why skeptics are cautious
The reaction online has been intense. Posts on Reddit communities like r/science and r/Futurology have drawn thousands of upvotes, and the story has been widely covered by ScienceAlert, New Atlas, Vice, ZME Science, Phys.org, and others.
That excitement is understandable, but caution is still warranted. Mouse-to-human translation often fails, especially in regenerative medicine. Human skin is more complex, our follicles behave differently, and long-term safety matters just as much as initial success.
Still, many optimists argue this case is different because it solves the cycling problem that blocked earlier attempts. That is the key scientific hurdle, and the RIKEN team appears to have cleared it in mice.
What the accessory mesenchymal cell discovery could mean next
The most interesting part of this story may not even be hair itself. The discovery of accessory mesenchymal cells could help researchers understand how to build other organs and tissues that need precise cell coordination and structural support. In regenerative medicine, that kind of insight can ripple outward in unexpected ways.
For now, though, the important takeaway is simple: this is a real proof of concept, not a cure. Human trials have not begun, and practical treatment is still years away. But for the first time, scientists have shown that lab-grown follicles can do what natural follicles do best — grow, rest, shed, and grow again.
If you’ve followed hair loss research for years, that is a genuinely meaningful milestone. The next step is to see whether the same biology can be safely and reliably adapted for people.
Stay tuned as researchers test whether this mouse breakthrough can become the next generation of hair restoration in humans.